Showing results (251-260 of 530) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|February 22, 2022
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trialShqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2022
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS)Malte Lenders, Peter Nordbeck, Christine Kurschat, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 15, 2019
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysisPaul M Haller, Patrick Sulzgruber, Christoph Kaufmann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 9, 2023
Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitorsMei-Zhen Wu, Tiew-Hwa Katherine Teng, Christopher Tze-Wei Tsang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2023
Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort studyYi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 23, 2023
Impact of transfusion strategy on platelet aggregation and biomarkers in myocardial infarction patients with anemiaJohanne Silvain, Benoit Lattuca, Etienne Puymirat, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 19, 2023
Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibitionEfthymios Ziogos, Stephen P Chelko, Tarek Harb, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2019
Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Per Grimfjärd, Bo Lagerqvist, David Erlinge, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 15, 2020
Low adherence to statin treatment during the 1st year after an acute myocardial infarction is associated with increased 2nd-year mortality risk-an inverse probability of treatment weighted study on 54 872 patientsKani Khalaf, Kristina Johnell, Peter C Austin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 19, 2020
Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass graftingKi Hong Choi, Young Bin Song, Dong Seop Jeong, et al.
Pageof 53